Earnings Releases

Hyatt Hotels Corp reported quarter ended March 31, 2024 results: net income $522 million, EPS $4.93.

“On May 9, 2024, Hyatt Hotels Corporation (the "Company") issued a press release announcing its results for its quarter ended March 31, 2024.”

DROPBOX, INC. reported the quarter ended March 31, 2024 results: revenue $631.3 million, net income $132.3 million, EPS $0.39.

“current report on Form 8-K and is incorporated by reference herein. --- EX-99.1 (EX-99.1) --- Dropbox Announces Fiscal 2024 First Quarter Results First Quarter Revenue of $631.3 Million, up 3.3% year-over-year; on a constant currency basis, up 3.2% year-over-year GAAP Operating Margin of 22.7% and Non-GAAP Operating Margin of 36.5% Net Cash Provided by Operating”

AMERICOLD REALTY TRUST reported first quarter ended March 31, 2024 results: revenue $665.0 million, net income $9.8 million, or $0.03 per diluted common share. Guidance raised.

“Australia, anchored by one of the country’s largest grocers, for a total investment of approximately $36 million US dollars.” First Quarter 2024 Highlights • Total revenue of $665.0 million, a 1.7% change from $676.5 million in Q1 2023.. • Total NOI increased 12.4% to $210.8 million from $187.6 million in Q1 2023. • Net income of $9.8 million, or $0.03 per diluted”

Teads Holding Co. reported the quarter ended March 31, 2024 results: revenue $217.0 million, net income $5.0 million.

“of our AI Creative Tools nearly doubled from Q4 2023 to Q1 2024, with 14% of our customer base utilizing Creative AI tools. First Quarter 2024 Financial Highlights: • Revenue of $217.0 million, a decrease of $14.8 million, or 6%, compared to $231.8 million in the prior year period. • Gross profit increased to $41.6 million, compared to $41.2 million in the prior year”

IRONWOOD PHARMACEUTICALS INC reported first quarter 2024 results: revenue $74,877, net income $(4,162), EPS $(0.03).

“growth, and delivering sustained profits and cash flow.” First Quarter 2024 Financial Highlights 1 (in thousands, except for per share amounts) Q1 2024 Q1 2023 Total revenue 2 $ 74,877 $ 104,061 Total operating expenses 63,857 43,964 GAAP net income (loss) 2 (4,162 ) 45,714 GAAP net income (loss) – per share basic 2 (0.03 ) 0.30 GAAP net income (loss) – per”

Mersana Therapeutics, Inc. reported first quarter ended March 31, 2024 results: revenue $9.2 million, net income $19.3 million net loss, EPS $0.16 per share.

“plan commitments into 2026. ● Net cash used in operating activities for the first quarter of 2024 was $32.7 million. · Collaboration revenue for the first quarter of 2024 was $9.2 million, compared to $7.8 million for the same period in 2023. The year-over-year change was primarily related to the company’s Johnson & Johnson collaboration, including both research”

EVERBRIDGE, INC. reported first quarter ended March 31, 2024 results: revenue $111.4 million, net income $(20.1) million, EPS $(0.49).

“Revenue for the first quarter was up 3% year-over-year to $111.4 million, and GAAP net loss was $(20.1) million, compared to $(14.6) million for the first quarter of 2023.”

Quest Resource Holding Corp reported the first quarter ended March 31, 2024 results: revenue $72.7 million, net income $(0.03) per share, EPS $(0.03).

“Quest Resource Holding Corporation (Nasdaq: QRHC) (“Quest”), a national leader in environmental waste and recycling services, today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights : • Revenue was $72.7 million, a 2.0% decrease compared with the first quarter of 2023. • Gross profit was $14.0 million, a 11.1% increase compared with the first quarter of 2023. • Gross margin was 19.3% of revenue, compared with 17.0% during the first quarter of 2023. • GAAP net loss per basic and diluted share attributable to common stockholders was $(0.03), compared with $(0.10) per share during the first quarter of 2023.”

Warner Bros. Discovery, Inc. reported the quarter ended March 31, 2024 results: revenue $9,958 million, net income $(966) million.

“or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- exhibit99-1wbd1q24earnin • Q1 total revenues were $9,958 million. Revenues decreased 7% ex-FX(1)(*) compared to the prior year quarter. • Net loss available to Warner Bros. Discovery, Inc. was $(966) million, and includes $1,879 million of”

Global Water Resources, Inc. reported the first quarter ended March 31, 2024 results: revenue total revenue decreased $1.5 million or 11.6% to $11.6 million, net income Net income was $0.7 million or $0.03 per share, EPS $0.03 per share.

“will hold a conference call at 1:00 p.m. Eastern time tomorrow to discuss the results (see dial-in information below). Q1 2024 Financial Highlights • Total revenue decreased $1.5 million or 11.6% to $11.6 million, primarily attributable to the recognition of $2.3 million in unregulated revenue related to infrastructure coordination and financing agreements”

FATE THERAPEUTICS INC reported financial results for the first quarter ended March 31, 2024.

“Fate Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2024.”

Blink Charging Co. reported the first quarter ended March 31, 2024 results: revenue $37.6 million. Guidance reaffirmed.

“expressly set forth by specific reference in such filing. --- EX-99.1 () --- EX-99.1 2 ex99-1.htm Exhibit 99.1 BLINK CHARGING ANNOUNCES FIRST QUARTER REVENUE GROWTH OF 73% TO $37.6 MILLION AND GROSS MARGIN OF 36% ● First quarter 2024 total revenues increased 73% to $37.6 million compared to $21.7 million in first quarter of 2023 ● 68% increase in product revenues”

IOVANCE BIOTHERAPEUTICS, INC. reported financial results for first quarter 2024.

“On May 9, 2024, Iovance Biotherapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2024”

Maiden Holdings, Ltd. reported financial results for the three months ended March 31, 2024.

“On May 9, 2024, the Company issued a press release announcing its results of operations for the three months ended March 31, 2024.”

CorMedix Inc. reported first quarter ended March 31, 2024 results: net income net loss of $14.5 million, EPS $0.25 per share.

“CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced financial results for the first quarter ended March 31, 2024”

CHIMERA INVESTMENT CORP reported first quarter ended March 31, 2024 results: net income GAAP NET INCOME OF $0.45 PER DILUTED COMMON SHARE, EPS $0.45 PER DILUTED COMMON SHARE.

“CHIMERA INVESTMENT CORPORATION REPORTS 1ST QUARTER 2024 EARNINGS”

AMERICAN COASTAL INSURANCE Corp reported financial results for first quarter ended March 31, 2024.

“AMERICAN COASTAL INSURANCE CORPORATION REPORTS FINANCIAL RESULTS FOR ITS FIRST QUARTER ENDED MARCH 31, 2024”

Genpact LTD reported second quarter of 2024 results: revenue $1.143 billion to $1.148 billion. Guidance initiated.

“Total revenue in the range of $1.143 billion to $1.148 billion, representing year-over-year growth of approximately 3.4% to 3.8% as reported, or 3.6% to 4.0% on a constant currency basis.”

Genpact LTD reported full year 2024 results: revenue $4.59 billion to $4.63 billion, EPS $3.01 to $3.04. Guidance raised.

“Total revenue in the range of $4.59 billion to $4.63 billion, representing year-over-year growth of approximately 2.5% to 3.5% as reported, or 2.7% to 3.7% on a constant currency basis, 1 up from the prior guidance of approximately 2.0% to 3.0% as reported.”

Genpact LTD reported first quarter ended March 31, 2024 results: revenue $1.13 billion, net income $117 million, EPS $0.64.

“Total Revenue of $1.13 billion, Up 4% 1,2,3 Diluted EPS of $0.64, Up 12%; Adjusted Diluted EPS 4 of $0.73, Up 7%”

iHeartMedia, Inc. reported the quarter ended March 31, 2024 results: revenue $799 million. Guidance reaffirmed.

“iHeartMedia, Inc. (Nasdaq: IHRT) today reported financial results for the quarter ended March 31, 2024. Financial Highlights: 1 Q1 2024 Consolidated Results ▪ Q1 Revenue of $799 million, down 1.5%; in line with guidance range of flat to down 2%”

ONE STOP SYSTEMS, INC. reported the first quarter ended March 31, 2024 results: revenue $12.7 million, net income a net loss of $1.3 million, or $0.06 per share, EPS $0.06 per share. Guidance initiated.

“within international defense and C5ISR market verticals, joined the Company as Business Development Executive. 2024 First Quarter Financial Summary Consolidated revenue was $12.7 million, a 24.6% decline from the prior year period. The year-over-year reduction in revenue was primarily a result of quarterly order fluctuations from a large defense customer and”

Main Street Capital CORP reported the first quarter ended March 31, 2024 results: revenue Total investment income of $131.6 million, net income Net investment income of $89.8 million (or $1.05 per share), EPS $1.05 per share.

“• Net investment income of $89.8 million (or $1.05 per share) • Distributable net investment income (1) of $94.4 million (or $1.11 per share) • Total investment income of $131.6 million • An industry leading position in cost efficiency, with a ratio of total non-interest operating expenses as a percentage of quarterly average total assets (“Operating Expenses to”

GREEN DOT CORP reported quarter ended March 31, 2024 results: revenue $451,988, net income $4,750, EPS $0.09.

“Results Summary Three Months Ended March 31, 2024 2023 % Change (In thousands, except per share data and percentages) GAAP financial results Total operating revenues $ 451,988 $ 416,380 9% Net income $ 4,750 $ 36,012 (87)% Diluted earnings per common share $ 0.09 $ 0.69 (87)% Non-GAAP financial results 1 Non-GAAP total operating revenues 1 $ 447,423 $”

Research Solutions, Inc. reported third quarter ended March 31, 2024 results: revenue $12.1 million, net income $76,000, EPS $0.00 per diluted share.

“reported financial results for its fiscal third quarter ended March 31, 2024. Fiscal Third Quarter 2024 Summary (compared to prior-year quarter) · Total revenue of $12.1 million, a 17% increase. · Platform revenue up 76% to $4.0 million. Annual Recurring Revenue (“ARR”) up 82% to $16.6 million, which includes approximately $11.7 million of B2B”

BERRY GLOBAL GROUP, INC. reported the quarter ended March 30, 2024 results: revenue $3.1 billion, EPS $0.98. Guidance reaffirmed.

“MAY 9, 2024) --- EX-99.1 2 exhibit.htm PRESS RELEASE DATED MAY 9, 2024 News Release Berry Announces Second Quarter 2024 Results Second Quarter Highlights • GAAP: Net sales of $3.1 billion; Operating income of $208 million; Earnings per share of $0.98 • Non-GAAP: Operating EBITDA of $522 million; Adjusted earnings per share of $1.95 • Second quarter volume and”

Larimar Therapeutics, Inc. reported first quarter ended March 31, 2024 results: net income $14.7 million, EPS $0.27 per share.

“The Company reported a net loss for the first quarter of 2024 of $14.7 million, or $0.27 per share, compared to a net loss of $6.5 million, or $0.15 per share, for the first quarter of 2023.”

ANAPTYSBIO, INC reported first quarter ended March 31, 2024 results: revenue $7.2 million.

“activities as well as a one-time non-operating cash payment of $10.9 million during the quarter. ◦ Reiterating cash runway through year-end 2026 • Collaboration revenue was $7.2 million for the three months ended March 31, 2024, compared to $1.4 million for the three months ended March 31, 2023. The change is due primarily to increased royalties”

Information Services Group Inc. reported financial results for first quarter ended March 31, 2024.

“On May 9, 2024 Information Services Group, Inc. (“ISG” or the “Company”) released its earnings for the first quarter 2024 which ended on March 31, 2024”

ADMA BIOLOGICS, INC. reported three months ended March 31, 2024 results: revenue $81.9 Million, net income $17.8 Million. Guidance raised.

“ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update 1Q 2024 Total Revenue of $81.9 Million, a 44% Increase Y-o-Y 1Q 2024 GAAP Net Income of $17.8 Million, a $24.6 Million Increase Y-o-Y”

Sally Beauty Holdings, Inc. reported second quarter ended March 31, 2024 results: revenue $908.4 million, net income $29.2 million, EPS $0.27 per diluted share.

“The Company will hold a conference call today at 7:30 a.m. Central Time to discuss these results and its business. Fiscal 2024 Second Quarter Summary • Consolidated net sales of $908 million, a decrease of 1.1% compared to the prior year; • Consolidated comparable sales decline of 1.5%; • Global e-commerce sales of $90 million, representing 9.9% of net sales; • GAAP”

Clean Energy Fuels Corp. reported first quarter ended March 31, 2024 results: revenue $103.7 million, net income $(18.4) million, EPS $(0.08) per share. Guidance reaffirmed.

“Clean Energy Reports Revenue of $103.7 Million and 58.0 Million RNG Gallons Sold for the First Quarter of 2024”

Primoris Services Corp reported the quarter ended March 31, 2024 results: revenue $1,412.7 million, net income $18.9 million, or $0.35 per diluted share.

“provided comments on the Company’s operational performance and outlook for 2024. ​ For the first quarter of 2024, Primoris reported the following highlights (1) : ● Revenue of $1,412.7 million, up $155.8 million, or 12.4 percent, compared to the first quarter of 2023 primarily driven by strong growth in utility-scale solar and industrial construction within the Energy”

Primoris Services Corp reported first quarter ended March 31, 2024 results: revenue $1,412.7 million, net income $18.9 million, or $0.35 per diluted share, EPS $0.35 per diluted share.

“provided comments on the Company’s operational performance and outlook for 2024. ​ For the first quarter of 2024, Primoris reported the following highlights (1) : ● Revenue of $1,412.7 million, up $155.8 million, or 12.4 percent, compared to the first quarter of 2023 primarily driven by strong growth in utility-scale solar and industrial construction within the Energy”

Hanesbrands Inc. reported first quarter ended March 30, 2024 results: revenue $1.16 billion. Guidance reaffirmed.

“Media contact: Nicole Ducouer (336) 986-7090 Analysts and Investors contact: T.C. Robillard (336) 519-2115 HanesBrands Announces First-Quarter 2024 Results • Net sales were $1.16 billion, the midpoint of the Company’s expected range. • GAAP and Adjusted gross margin of 39.9% increased 750 and 720 basis points, respectively, compared to prior year, ahead of”

INTELLIGENT PROTECTION MANAGEMENT CORP. reported first quarter ended March 31, 2024 results: revenue $2.6 million, net income Net loss was $0.5 million.

“for the first quarter ended March 31, 2024. Key Financial Highlights for First Quarter Ended March 31, 2024 Compared to Prior Year Period ● Total Revenue increased 1.3% to $2.6 million ● Subscription revenue decreased 0.9% to $2.5 million ● Advertising revenue increased 96.7% to $0.1 million ● Net loss was $0.5 million compared to a net loss of $0.7 million, an”

EPAM Systems, Inc. updated its For the second quarter guidance (initiated).

“For the second quarter, EPAM expects revenues to be in the range of $1.135 billion to $1.145 billion, GAAP diluted EPS to be in the range of $1.52 to $1.60 and non-GAAP diluted EPS to be in the range of $2.21 to $2.29”

EPAM Systems, Inc. updated its for the full year guidance (lowered).

“For the full year, EPAM updates expected revenues to now be in the range of $4.575 billion to $4.675 billion, updates expected GAAP diluted EPS to now be in the range of $7.34 to $7.64 and narrows expected range for non-GAAP diluted EPS to $10.00 to $10.30”

EPAM Systems, Inc. reported the first quarter ended March 31, 2024 results: revenue $1.165 billion, EPS $1.97. Guidance reaffirmed.

“• First quarter revenues of $1.165 billion, down 3.8% year-over-year •”

InfuSystem Holdings, Inc reported first quarter ended March 31, 2024 results: revenue Net revenues totaled $32.0 million, net income Net loss was $1.1 million, EPS $(0.05) per diluted share.

“• Net revenues totaled $32.0 million, an increase of 5% vs. prior year. ◦ Patient Services net revenue was $18.6 million, a decrease of 1% vs. prior year. ◦ Device Solutions net revenue was $13.4 million, an increase of 16% vs. prior year. • Gross profit was $16.5 million, an increase of 10% vs. prior year. • Gross margin was 51.5%, an increase of 2.3% vs. prior year. ◦ Patient Services gross margin was 66.0%, an increase of 4.5% vs. prior year. ◦ Device Solutions gross margin was 31.3%, an increase of 1.9% vs. prior year. • Net loss was $1.1 million, or $(0.05) per diluted share vs. prior year net loss of $0.3 million, or $(0.02) per diluted share.”

Clear Channel Outdoor Holdings, Inc. reported Full Year 2024 results: revenue $2,200 million to $2,260 million, net income -$150 million to -$120 million. Guidance reaffirmed.

“Our expectations for the full year of 2024 have not changed from the guidance we provided in our earnings release issued on February 26, 2024, except for loss from continuing operations and Adjusted Funds from Operations (“AFFO”). Our updated expectations for the full year of 2024 are as follows: Full Year of 2024 % change from prior year (in millions) Low High Low High Consolidated Revenue 1,2 $ 2,200 $ 2,260 3 % 6 %”

Clear Channel Outdoor Holdings, Inc. reported Q2 2024 results: revenue $547 million to $572 million. Guidance reaffirmed.

“Our expectations for the second quarter of 2024 are as follows: Second Quarter of 2024 % change from prior year (in millions) Low High Low High Consolidated Revenue 1,2 $ 547 $ 572 3 % 8 %”

Clear Channel Outdoor Holdings, Inc. reported financial results for Q1 2024.

“Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) (the “Company”) today reported financial results for the quarter ended March 31, 2024. “We delivered first quarter consolidated revenue of $482 million, an increase of 10.1%, or 9.3% excluding movements in foreign exchange rates, reflecting record first quarter results in our America, Airports and Europe-North segments excluding sold markets and movements in foreign exchange rates,””

YELP INC reported the first quarter ended March 31, 2024 results: revenue $333 million, net income $14 million, EPS $0.20 per diluted share.

“Net revenue was $333 million, up 7% from the first quarter of 2023 and consistent with our first quarter outlook range, driven primarily by growth in advertising revenue as we executed against our strategic initiatives. > Net income was $14 million, or $0.20 per diluted share, representing a net income margin of 4%, compared to net loss of ($1) million, or ($0.02) per diluted share, and a net loss margin of approximately zero in the first quarter of 2023.”

FEMASYS INC reported first quarter ended March 31, 2024 results: revenue $271,140, net income $3,599,510, EPS $0.17.

“Quarter Ended March 31, 2024 • Research and development expenses increased by $233,292 to $1,770,731 in Q1 of 2024 from $1,537,439 in Q1 of 2023 • Sales decreased by $22,844 to $271,140 in Q1 of 2024 from $293,984 in Q1 of 2023 • Net loss was $3,599,510 or $0.17 per basic and diluted share attributable to common stockholders, for the quarter ended March 31, 2024,”

MERCER INTERNATIONAL INC. reported first quarter ended March 31, 2024 results: revenue $553,430, net income $16.7 million (or $0.25 per share).

“stable in the second quarter of 2024 as a result of steady demand. Consolidated Financial Results Q1 Q4 Q1 2024 2023 2023 (in thousands, except per share amounts) Revenues $ 553,430 $ 470,494 $ 522,666 Operating loss $ (448 ) $ (56,395 ) $ (20,121 ) Operating EBITDA $ 63,601 $ 21,145 $ 27,470 Net loss $ (16,703 ) $ (87,216 ) $ (30,578 ) Net loss per common”

Xencor Inc reported the first quarter ended March 31, 2024 results: revenue $12.8 million, net income $68.0 million, or $(1.11) on a fully diluted per share basis, EPS $(1.11) on a fully diluted per share basis.

“marketable debt securities totaled $646.7 million as of March 31, 2024, compared to $697.4 million on December 31, 2023. Revenues for the first quarter ended March 31, 2024 were $12.8 million, compared to $19.0 million for the same period in 2023. Total revenues earned in the first quarter of 2024 included non-cash royalty revenue from Xencor’s Alexion and”

Altimmune, Inc. reported the first quarter ended March 31, 2024 results: net income Net loss for the three months ended March 31, 2024 was $24.4 million, or $0.34 net loss per share, EPS $0.34 net loss per share.

“● Net loss for the three months ended March 31, 2024 was $24.4 million, or $0.34 net loss per share, compared to a net loss of $20.1 million, or $0.40 net loss per share, in the same period in 2023.”

LENSAR, Inc. reported quarter ended March 31, 2024 results: revenue $10.6 million, net income $2.2 million, EPS ($0.19) per common share.

“and staff as well as better surgical outcomes for patients, allowed us to deliver continued 20%+ revenue growth in the first quarter of 2024. Total revenue for the quarter was $10.6 million, up 28% over the first quarter of 2023. Moreover, procedure volume grew by 23% in the U.S., our largest market and the only country where ALLY is currently marketed,” said Nick”

Warner Music Group Corp. reported for the quarter ended March 31, 2024 results: revenue $1,494, net income $96 million. Guidance reaffirmed.

“Ended March 31, 2023 % Change For the Six Months Ended March 31, 2024 For the Six Months Ended March 31, 2023 % Change (unaudited) (unaudited) (unaudited) (unaudited) Revenue $ 1,494 $ 1,399 7 % $ 3,242 $ 2,887 12 % Recorded Music revenue 1,189 1,143 4 % 2,634 2,382 11 % Music Publishing revenue 306 257 19 % 610 507 20 % Operating income 119 124 -4 % 473 389”